学术英语+医学+unit3.pptVIP

Writing Suggested answers Task 2 2. Simple past In two previous efficacy trials of an HSV-2 glycoprotein D–based subunit (gD-2) vaccine in discordant couples in which one partner had recurrent HSV genital disease, the subset of seronegative women (negative for both HSV-1 and HSV-2 antibodies) was significantly protected against HSV-2 disease by the vaccine (73% and 74% efficacy, respectively); efficacy was not shown in either men or HSV-1–seropositive women. 第六十三页，共67页。 Writing Suggested answers Task 2 3. Simple past To further evaluate the gD-2 vaccine as a potential public health tool, we